Session Chair Profile

M.D., Chief Medical Officer, Foundation Medicine

Dr. Miller was appointed to serve as our Chief Medical Officer on July 31, 2013. He joined Foundation Medicine in October 2011 and served as our Senior Vice President, Clinical Development between then and July 2013. Dr. Miller previously served as an attending physician at Memorial Sloan-Kettering Cancer Center between July 1991 and October 2011. His work in clinical and translational research in lung cancer culminated in observations and collaborative efforts critical to identification of EGFR sensitizing and resistance mutations. He is considered a world’s expert in lung cancer and clinical trial design and interpretation. Dr. Miller has authored and co-authored numerous abstracts, reviews, and peer-reviewed articles, which have appeared in such journals as Proceedings of the National Academy of Science USA, Cancer Research, Clinical Cancer Research and the Journal of Clinical Oncology. Dr. Miller, a National Merit Scholar, received a BA in mathematics at the University of Pennsylvania, where he was honored as a Benjamin Franklin Scholar, and an MD at the University of Medicine and Dentistry of New Jersey in Newark. He completed an internship and residency, and then served as Chief Medical Resident in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia, and subsequently a fellowship in Medical Oncology at Memorial Sloan-Kettering Cancer Center.

Session Abstract

Session Synopsis: The impact of precision medicine in oncology is undeniable. Precision diagnosis and treatment of cancer at the molecular level has profound implications on the outcome, but requires physician awareness, understanding, and adoption to deliver successful personalized treatment for cancer patients. This session will share the challenges to create a process for organizational and physician engagement while they incorporate precision oncology into practice.